CRISPR Therapeutics
CRSP
#3582
Rank
ยฃ2.96 B
Marketcap
ยฃ30.56
Share price
0.10%
Change (1 day)
-24.80%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): -ยฃ3.56

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ3.60. In 2025 the company made an earnings per share (EPS) of -ยฃ4.96 a decrease over its 2024 EPS that were of -ยฃ3.32.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.56-28.2%
2025-ยฃ4.9649.2%
2024-ยฃ3.32
2022-ยฃ6.37-267.74%
2021ยฃ3.79
2019ยฃ0.84-132.36%
2018-ยฃ2.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA